Branded Generics Market 2026 Size, Share, Business Opportunity, Innovation, Future Growth, Key Findings | FMI Report

1
Branded Generics Market

• January 2017

Report Id REP-GB-1260 Status
Published Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
PMR formulates a detailed discussion guide to conduct expert and industry interviews
PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts
PMR conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
PMR delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Branded Generics Market

• Branded Generics Market Is Expected To Generate
  Huge Profits by 2019-2026 Mylan N.V., Novartis
  AG, Teva Pharmaceutical Industries Ltd
• VALLEY COTTAGE, N.Y.  Differential and
  innovative product strategies that are adopted by
  various multinational pharma companies have been
  fuelling the growth of branded generics market at
  a global scale. These strategies include
  establishing sustained local capabilities with
  the strong local talents, engaging in portfolio
  marketing, recalibrating regulatory affairs,
  bolstering sales force with the multi-channel
  engagement and enhancing contracting
  capabilities. Developing regions are witnessing a
  rapid increase in demand for branded generics on
  account of increasing affordability of the
  products and ease of regulations. Rising
  disposable income and changing lifestyle of
  consumers is also expected to augur well for
  growth of the Industry in the near future.
• The study predicts that patent expiries of the
  blockbuster drugs are likely to create demand for
  branded generics during the forecast period.
  Increasing prevalence of the lifestyle and
  chronic diseases such as cardiovascular diseases
  and diabetes together with increasing purchasing
  power makes Business attractive for investors.
  The study by Future Market Insights predicts that
  branded generics market is likely to register a
  healthy 7.3 CAGR over the forecast period,
  2016-2026. Commodity generic products and huge
  competition from the branded drugs have prevailed
  as major challenges inhibiting the growth of
  Industry, in terms of price structure.

5
Branded Generics Market

• Cardiovascular Diseases are likely to prove
  highly lucrative for revenue growth of branded
  generics market due to rising prevalence of
  diverse types of cancers and increasing
  comorbidities across the globe. Anti-hypertensive
  segment is expected to prove highly lucrative for
  the purpose of reducing premature cardiovascular
  disease. Oral formulations hold the largest
  demand from medical providers and patients for
  branded generics. This is mainly due to the
  benefits that oral formulation offers such as
  accuracy, dosing convenience and easy adherence
  to a medication plan.
• Download Sample Copy_at_ https//www.futuremarketinsi
  ghts.com/reports/sample/rep-gb-1260
• Cardiovascular Diseases are likely to prove
  highly lucrative for revenue growth of branded
  generics market due to rising prevalence of
  diverse types of cancers and increasing
  comorbidities across the globe. Anti-hypertensive
  segment is expected to prove highly lucrative for
  the purpose of reducing premature cardiovascular
  disease. Oral formulations hold the largest
  demand from medical providers and patients for
  branded generics. This is mainly due to the
  benefits that oral formulation offers such as
  accuracy, dosing convenience and easy adherence
  to a medication plan.
• Parenteral formulations are likely to gain
  traction in the Industry during the forecast
  period, with API (active pharmaceutical
  ingredient) being degraded in intestinal tracts,
  thereby driving the demand for parenteral
  delivery.

6
Branded Generics Market

• The report predicts that APEJ and North America
  are likely to remain lucrative for parenteral
  formulations during the forecast period. Retail
  Pharmacies are expected to prove as the most
  lucrative distribution channel for branded
  generics, as the pharmaceutical companies
  manufacturers are highly dependent on this
  distribution channel for selling the products
  over-the-counter. 
• APEJ accounts for the largest revenue share in
  the branded generics market owing to lack of
  worldwide health coverage and higher
  out-of-the-pocket expenditure on healthcare.
  China, India and ASEAN countries are expected to
  pose lucrative growth opportunities for the new
  and existing key players in the forthcoming
  years. Most of the leading manufacturers in the
  global market are concentrated in Asian countries
  and have been working towards expansion of their
  production capacity, for catering to the existing
  and emerging global demands.

7
Branded Generics Market

• Statutory regulatory bodies have been playing a
  significant role in the growth of market in APEJ
  by providing approvals for products. Furthermore,
  growth through the adoption of inorganic
  approaches have been forming cornerstone of the
  branded generics drug makers in APEJ region.
  Latin America, Eastern Europe and North America
  will prove significantly lucrative for the market
  in the forthcoming years.
• Ask an Analyst _at_ https//www.futuremarketinsights.
  com/ask-the-analyst/rep-gb-1260
•  Brand-name prescriptions are anticipated to
  remain ubiquitous amongst the aged people
  worldwide. Since geriatric demographics hold a
  larger portion of drug-consuming population
  across the globe, demand for branded generics are
  expected to rise substantially. Branded generics
  market has been projected to develop at a healthy
  pace as enormous number of the pharmaceutical
  products are expected to go off-patent within the
  assessment period of 2016-2026

8
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHarish Tiwari (General
Manager Global Head Business Development)
Future Market Insights 3rd Floor,207 Regent
Street, London W1B 3HH T 44 20 7692 8790 D
44 20 3287 4268 Email hari.t_at_futuremarketinsight
s.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)